The commission overruled part of Montefarma's tender: Medicines on hold again

The commission decided that the procedure for selecting 48 parties was not in accordance with the law and ordered a reevaluation
2 comment(s)
Medicines, tablets, pills, Photo: Shutterstock
Medicines, tablets, pills, Photo: Shutterstock
Disclaimer: The translations are mostly done through AI translator and might not be 100% accurate.
Ažurirano: 17.10.2013. 07:20h

The Commission for the Control of the Public Procurement Procedure rejected a part of the tender for the procurement of medicines and medical devices that the Pharmacy Institution "Montefarm" announced back in July.

The value of the tender is almost three million euros, and the procurement is planned for 147 types of medicines and medical devices, many of which are currently in short supply.

The commission headed by Suzana Pribalić decided that the procedure for selecting 48 parties was not in accordance with the law and ordered a reevaluation.

The Commission indicated, among other things, that the Law on Public Procurement was violated in those cases because there were omissions in the procedure of review, assessment, comparison and evaluation of bids, and especially the absence of reasons and evidence on the basis of which the decision was made.

As they stated, in the public procurement procedure, the provisions of the Law on the Use of Languages ​​and Letters were violated, and incorrect offers were chosen as the most favorable.

Health officials have repeatedly blamed the tender procedure for frequent shortages of drugs and medical supplies

The Commission emphasized that the offers of the company Glosarij, which were selected as the most favorable, were not properly adopted, since they were not submitted in Montenegrin or another language that is in official use. She made a similar finding for some jobs that were assigned to the companies "Dubai", "Farmegra", Belgrade-based "Ino pharm", "Osmo redu D". The offer of the company "DPG" from Podgorica, according to the opinion of the Commission, was unjustifiably chosen as the most favorable, because it did not provide valid evidence about the quality of the offered product.

Health officials have repeatedly blamed the tender procedure for frequent shortages of drugs and medical supplies.

Public procurement in healthcare will also be the subject of a control hearing before the Parliamentary Committee for Health, Labor and Social Welfare, scheduled for October 25.

Bonus video: